This inventor holds 2 USPTO granted patents. Top assignee: Astrazeneca Ab. Active years: 2007-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Reims Cedex 2, FR (2007)
- Reims, FR (2009)
Company Filing History:
Years Active: 2007-2009
Title: The Innovative Contributions of Mickael Louis Pierre Maudet
Introduction
Mickael Louis Pierre Maudet is a notable inventor based in Reims, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target gonadotropin-releasing hormone (GnRH). With a total of 2 patents to his name, Maudet's work is paving the way for advancements in the treatment of hormone-related conditions.
Latest Patents
Mickael Maudet's latest patents include innovative compounds that serve as antagonists of GnRH. One of his notable inventions involves derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole, which are aimed at treating sex hormone-related conditions such as prostatic and uterine cancer. This invention details a group of novel pyrazole compounds that are useful in pharmaceutical formulations and methods of treatment. Another significant patent focuses on pyrazole derivatives as GnRH inhibitors, which also includes a group of novel thieno-pyrrole compounds. These compounds are similarly designed to act as GnRH antagonists, contributing to the development of effective treatments.
Career Highlights
Mickael Maudet is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions are vital in the ongoing efforts to create effective therapies for hormone-related diseases.
Collaborations
Throughout his career, Maudet has collaborated with esteemed colleagues such as Matthias Ferdinand Herdemann and Thomas Geoffrey Bird. These collaborations have fostered a productive environment for innovation and have led to the successful development of new pharmaceutical compounds.
Conclusion
Mickael Louis Pierre Maudet's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations are instrumental in advancing treatments for hormone-related conditions, showcasing the importance of research and development in improving healthcare outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile